title: Microbial translocation and metabolic and body composition measures in treated and untreated HIV infection.
abstract: Circulating levels of microbial products such as lipopolysaccharide (LPS) are increased in HIV infection. Microbial translocation promotes obesity, insulin resistance, and dyslipidemia in other settings. We examined data from 178 subjects: an Indiana University (IU) cross-sectional study [N=49 on antiretroviral therapy (ART), N=47 not on ART], and a 24 week prospective study of ART initiation ACTG 5152s (N=82). Pearson correlations were used to describe relationships of plasma LPS levels and soluble CD14 (sCD14), a marker of monocyte activation, with metabolic and body composition measures. HOMA-IR (a measure of insulin resistance) and LPS were correlated for the combined cohorts (r=0.19, p=0.02), particularly in the 5152s ART-naive cohort (r=0.41, p<0.01). Triglycerides were correlated with LPS in the combined cohort (r=0.32, p<0.01), and all subsets excluding the IU on ART subset. There were negative correlations between sCD14 and high-density lipoprotein (HDL) cholesterol in all subjects (r=-0.21, p<0.01), as well as the IU subset not on ART (r=-0.32, p=0.04). Large particle HDL as measured by NMR spectroscopy, but not HDL cholesterol, was negatively correlated with LPS (r=-0.18, p=0.02), particularly among the IU subset receiving ART (r=-0.33, p=0.03). In the combined cohorts, sCD14 was negatively correlated with lean mass as well as trunk and limb fat. There is a relationship between microbial translocation markers and metabolic effects, particularly lipoproteins. During prolonged ART, microbial translocation was associated with an adverse effect on large HDL and thus may contribute to the increased cardiovascular disease risk observed during chronic treatment of HIV.
authors.affiliation: 1 Department of Medicine, University of Southern California Keck School of Medicine , Los Angeles, California.
authors.forename: Tamara
authors.initials: T
authors.lastname: Timmons
authors.forename: Changyu
authors.initials: C
authors.lastname: Shen
authors.forename: Grace
authors.initials: G
authors.lastname: Aldrovandi
authors.forename: Adrienne
authors.initials: A
authors.lastname: Rollie
authors.forename: Samir K
authors.initials: SK
authors.lastname: Gupta
authors.forename: James H
authors.initials: JH
authors.lastname: Stein
authors.forename: Michael P
authors.initials: MP
authors.lastname: Dubé
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018988:Bacterial Translocation; D001823:Body Composition; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000473:pathology*; D006785:Hospitals, University; D006801:Humans; D007196:Indiana; D018950:Lipopolysaccharide Receptors / Q000097:blood; D008070:Lipopolysaccharides / Q000097:blood; D008297:Male; D055442:Metabolome; D008875:Middle Aged
chemical_list: D044966:Anti-Retroviral Agents; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides
references.citation: Nat Med. 2006 Dec;12(12):1365-71
references.pmid: 17115046
references.citation: PLoS One. 2012;7(8):e42624
references.pmid: 22952600
references.citation: AIDS. 2009 Jun 1;23(9):1109-18
references.pmid: 19417580
references.citation: J Infect Dis. 2011 Mar 15;203(6):780-90
references.pmid: 21252259
references.citation: Nutr Clin Pract. 2012 Apr;27(2):215-25
references.pmid: 22378797
references.citation: J Infect Dis. 2011 Oct 15;204(8):1227-36
references.pmid: 21917896
references.citation: Atherosclerosis. 2009 Nov;207(1):111-5
references.pmid: 19515370
references.citation: Infect Immun. 2005 Apr;73(4):2321-6
references.pmid: 15784577
references.citation: J Am Coll Cardiol. 2008 Aug 12;52(7):569-76
references.pmid: 18687253
references.citation: Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E740-7
references.pmid: 17090751
references.citation: Diabetes Care. 2010 Sep;33(9):1925-32
references.pmid: 20530747
references.citation: J Virol. 2003 Nov;77(21):11708-17
references.pmid: 14557656
references.citation: Trends Immunol. 2010 Jun;31(6):228-35
references.pmid: 20434953
references.citation: Clin Chim Acta. 2006 Apr;366(1-2):156-62
references.pmid: 16253217
references.citation: Atherosclerosis. 2009 Dec;207(2):524-9
references.pmid: 19515371
references.citation: J Infect Dis. 2009 Apr 15;199(8):1177-85
references.pmid: 19265479
references.citation: AIDS Res Hum Retroviruses. 2010 Aug;26(8):847-54
references.pmid: 20673142
references.citation: N Engl J Med. 2005 Jan 6;352(1):48-62
references.pmid: 15635112
references.citation: Diabetes. 2007 Jul;56(7):1761-72
references.pmid: 17456850
references.citation: Blood. 1998 Sep 15;92(6):2084-92
references.pmid: 9731066
references.citation: Circulation. 2009 Feb 24;119(7):931-9
references.pmid: 19204302
references.citation: J Clin Endocrinol Metab. 2003 Apr;88(4):1780-4
references.pmid: 12679473
references.citation: Biochem Biophys Res Commun. 2006 Aug 4;346(3):739-45
references.pmid: 16781673
references.citation: Nat Immunol. 2006 Mar;7(3):235-9
references.pmid: 16482171
references.citation: PLoS One. 2011;6(6):e21275
references.pmid: 21731690
references.citation: Endocr Rev. 2010 Dec;31(6):817-44
references.pmid: 20592272
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825
references.citation: J Infect Dis. 2012 Nov 15;206(10):1558-67
references.pmid: 23066162
references.citation: N Engl J Med. 2008 May 15;358(20):2095-106
references.pmid: 18480202